Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Chongqing Zhifei Biological Products Co Ltd
Cash from Financing Activities
Chongqing Zhifei Biological Products Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
|
Beigene Ltd
HKEX:6160
|
Cash from Financing Activities
-¥448.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Financing Activities
¥2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Financing Activities
-¥893.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Financing Activities
-¥1.1B
|
CAGR 3-Years
-164%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Financing Activities
-¥374.2m
|
CAGR 3-Years
-104%
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
See Also
What is Chongqing Zhifei Biological Products Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-2.4B
CNY
Based on the financial report for Sep 30, 2023, Chongqing Zhifei Biological Products Co Ltd's Cash from Financing Activities amounts to -2.4B CNY.
What is Chongqing Zhifei Biological Products Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-39%
Over the last year, the Cash from Financing Activities growth was -95%. The average annual Cash from Financing Activities growth rates for Chongqing Zhifei Biological Products Co Ltd have been -5% over the past three years , and -39% over the past ten years .